CRWV is trading at $113.31 (-12.05%) as investors weigh a wider-than-expected net loss and aggressive CapEx spending against a Q1 revenue beat.
- Q1 revenue reached $2.078B with a backlog nearing $100B, but a net loss of ($1.40) per share and heavy capital expenditure plans pressured sentiment.
- The stock is bucking a bullish market trend (Nasdaq +1%), suggesting company-specific selling pressure following the May 7 earnings report.
- Options activity remains elevated with an implied move of ±$15.70 as post-earnings digestion continues.